Clinical Trial Update: Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer [Phase 2]

View source ↗

Summary

Phase 2 exploratory study evaluating surgery plus GLIADEL wafers for metastatic brain cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• GLIADEL (Carmustine)

Snippet

Sponsor: Eisai Inc. | Conditions: Metastatic Brain Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-16